Report cover image

MeMed Diagnostics Ltd - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 42 Pages
SKU # GBDT21121819

Description

Summary

MeMed Diagnostics Ltd (MeMed) is a developer of diagnostic solutions for inflammatory and infectious diseases. It develop tests that integrate these biomarker measurements for more accurate understanding of a patient’s condition. The company offers MeMed BV which is the host-immune response assay for accurately distinguishing between bacterial and viral infections and MeMed Key which is a cutting-edge, compact immunoassay platform to conduct highly sensitive, quick, multiplexed protein measurements that previously could only be done on large, expensive central lab equipment. MeMed is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MeMed Diagnostics Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

42 Pages
MeMed Diagnostics Ltd Company Overview
MeMed Diagnostics Ltd Company Snapshot
MeMed Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
MeMed Diagnostics Ltd – Pipeline Analysis Overview
MeMed Diagnostics Ltd - Key Facts
MeMed Diagnostics Ltd - Major Products and Services
MeMed Diagnostics Ltd Pipeline Products by Development Stage
MeMed Diagnostics Ltd Ongoing Clinical Trials by Trial Status
MeMed Diagnostics Ltd Pipeline Products Overview
Diagnostic Test - COVID-19
Diagnostic Test - COVID-19 Product Overview
ImmunoPoC
ImmunoPoC Product Overview
MeMed Alert
MeMed Alert Product Overview
MeMed BV Flex
MeMed BV Flex Product Overview
MeMed ImmunoRNA
MeMed ImmunoRNA Product Overview
MeMed Neo
MeMed Neo Product Overview
MeMed Severity
MeMed Severity Product Overview
MeMed Severity Clinical Trial
MeMed Ultra Flu
MeMed Ultra Flu Product Overview
MeMed Universal Severity
MeMed Universal Severity Product Overview
MeMed Diagnostics Ltd - Key Competitors
MeMed Diagnostics Ltd - Key Employees
MeMed Diagnostics Ltd - Locations And Subsidiaries
Head Office
Recent Developments
MeMed Diagnostics Ltd, Recent Developments
Apr 13, 2026: Beckman Coulter obtains CE mark for bacterial-viral differentiator test
Mar 25, 2026: MeMed Expands Global Footprint as Health Canada Approves MeMed BV on MeMed Key
Mar 11, 2026: FDA Grants Breakthrough Device Designation to MeMed BV Flex Capillary Blood
Jan 12, 2026: MeMed Awarded $2 Million Grant to Establish Acute-Care Digital and Physical Biobank
Sep 04, 2025: New Evidence on Memed Bv’s Role in Supporting Emergency Medicine Clinical Decisions Unveiled at ACEP 2025
Jul 24, 2025: MeMed Completes Development of First-Ever Fingerstick Host-Response Test for Rapid Differentiation of Bacterial and Viral Infections
Jun 05, 2025: MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics
Jun 05, 2025: MeMed Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics
Feb 27, 2025: Memed BV Proven To Optimize Antibiotic Use, Outperform Standard Care, and Cut Costs in New Studies
Jan 09, 2025: MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
MeMed Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
MeMed Diagnostics Ltd Pipeline Products by Equipment Type
MeMed Diagnostics Ltd Pipeline Products by Indication
MeMed Diagnostics Ltd Ongoing Clinical Trials by Trial Status
MeMed Diagnostics Ltd, Key Facts
MeMed Diagnostics Ltd, Major Products and Services
MeMed Diagnostics Ltd Number of Pipeline Products by Development Stage
MeMed Diagnostics Ltd Pipeline Products Summary by Development Stage
MeMed Diagnostics Ltd Ongoing Clinical Trials by Trial Status
MeMed Diagnostics Ltd Ongoing Clinical Trials Summary
Diagnostic Test - COVID-19 - Product Status
Diagnostic Test - COVID-19 - Product Description
ImmunoPoC - Product Status
ImmunoPoC - Product Description
MeMed Alert - Product Status
MeMed Alert - Product Description
MeMed BV Flex - Product Status
MeMed BV Flex - Product Description
MeMed ImmunoRNA - Product Status
MeMed ImmunoRNA - Product Description
MeMed Neo - Product Status
MeMed Neo - Product Description
MeMed Severity - Product Status
MeMed Severity - Product Description
MeMed Severity - A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections
MeMed Ultra Flu - Product Status
MeMed Ultra Flu - Product Description
MeMed Universal Severity - Product Status
MeMed Universal Severity - Product Description
MeMed Diagnostics Ltd, Key Employees
Glossary
List of Figures
MeMed Diagnostics Ltd Pipeline Products by Equipment Type
MeMed Diagnostics Ltd Pipeline Products by Development Stage
MeMed Diagnostics Ltd Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us